You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nonmuscle invasive bladder cancer (NMIBC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urine-based Molecular Testing vs Cystoscopy for Surveillance of

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • +2 more
  • CxBladder Monitor
  • Cystoscopy
  • Scottsdale, Arizona
  • +2 more
Nov 14, 2023

Urinary Bladder Cancer Trial in Tucson (Gemcitabine)

Not yet recruiting
  • Urinary Bladder Cancer
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 21, 2022

Non-muscle Invasive Bladder Cancer (NMIBC) Trial in New York, Nashville (ABI-009, Gemcitabine)

Completed
Has Results
  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • New York, New York
  • +1 more
May 12, 2021

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Uromonitor asBiomarker for Optimization of NMIBC Management by

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    May 9, 2023

    Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

    Not yet recruiting
    • Non-Muscle Invasive Bladder Cancer
    • HER2
    • (no location specified)
    Jul 16, 2023

    Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

    Recruiting
    • Non Muscle Invasive Bladder Cancer
    • N803 plus Bacillus Calmette-Guerin (BCG)
    • Honolulu, Hawaii
      Island Urology
    Aug 7, 2023

    Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
      • (no location specified)
      Apr 11, 2023

      Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

      Not yet recruiting
      • Non-Muscle- Invasive Bladder Cancer
      • Durvalumab
      • BCG
      • (no location specified)
      Jul 5, 2023

      Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

      Recruiting
      • Urothelial Carcinoma
      • Non-Invasive Bladder Urothelial Carcinoma
      • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
      • Tampa, Florida
        Moffitt Cancer Center
      Mar 2, 2023

      Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

      Not yet recruiting
      • Non Muscle Invasive Bladder Cancer
      • +3 more
      • Cretostimogene Grenadenorepvec
      • n-dodecyl-B-D-maltoside
      • (no location specified)
      Oct 30, 2023

      Bladder Cancer Trial in Nara, Okayama (FE 999326)

      Recruiting
      • Bladder Cancer
      • FE 999326
      • Nara, Japan
      • +1 more
      Jan 19, 2023

      Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)

      Terminated
      • Non-muscle Invasive Bladder Cancer (NMIBC)
      • Hyaluronic Acid (HA) sodium salt and Hydeal-D
      • Rozzano, Mi, Italy
        Humanitas Research Hospital
      Sep 29, 2023

      Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

      Active, not recruiting
      • Non-muscle-invasive Bladder Cancer
      • Gemcitabine 1000 mg, Docetaxel 37.5g
      • Zagreb, Croatia
        University Hospital Centre Zagreb
      Jan 20, 2023

      Bladder Cancer Trial in Aarhus (Mitomycin c)

      Active, not recruiting
      • Bladder Cancer
      • Mitomycin c
      • Aarhus, Denmark
        Aarhus University Hospital
      Aug 5, 2022

      Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
      • (no location specified)
      Sep 9, 2022

      Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

      Active, not recruiting
      • Bladder Cancer
      • +2 more
      • Homewood, Alabama
      • +4 more
      Dec 15, 2022

      Non-muscle-invasive Bladder Cancer Trial in Xi'an (Standard infusion chemo, BL - 5 ala PDT)

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
      • Standard infusion chemotherapy
      • BL - 5 ala PDT
      • Xi'an, Shaanxi, China
        Dalin He
      Sep 19, 2022

      Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

      Recruiting
      • Non-muscle Invasive Bladder Cancer
      • +5 more
      • Little Rock, Arkansas
      • +7 more
      Dec 19, 2022

      Non-muscle-invasive Bladder Cancer Trial in Myrtle Beach, Nashville (AU-011, AU-011 in Combination with Medical Laser)

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
      • AU-011
      • AU-011 in Combination with Medical Laser
      • Myrtle Beach, South Carolina
      • +1 more
      Jul 29, 2022

      Bladder Cancer Trial (pembrolizumab)

      Active, not recruiting
      • Bladder Cancer
      • Pembrolizumab
      • +2 more
      • (no location specified)
      Oct 11, 2022

      Bladder Cancer, Bladder Cancer Recurrent, Tumor Recurrence Trial (Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus

      Not yet recruiting
      • Bladder Cancer
      • +5 more
      • Bacillus Calmette-Guerin: Strain Russian BCG-I
      • Bacillus Calmette-Guerin: Strain TICE
      • (no location specified)
      Apr 7, 2022

      Urinary Bladder Tumors Trial in München (Catumaxomab)

      Recruiting
      • Urinary Bladder Neoplasms
      • München, Germany
        Urologie Planegg
      Apr 4, 2022

      Invasive Bladder Cancer Trial in Madrid (Atezolizumab, BCG)

      Recruiting
      • Invasive Bladder Cancer
      • Madrid, Spain
        Hospital 12 de Octubre
      Feb 8, 2022

      Non-muscle Invasive Bladder Cancer Trial in Shanghai (APL-1202 in combination with Epirubicin, Placebo in combination with

      Active, not recruiting
      • Non-muscle Invasive Bladder Cancer
      • APL-1202 in combination with Epirubicin
      • Placebo in combination with Epirubicin
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Feb 21, 2022